专题：Ovarian cancer diagnosis and treatment

This cluster of papers encompasses an extensive exploration of ovarian cancer, including genomic analyses, treatment strategies such as chemotherapy and cytoreductive surgery, identification of biomarkers, investigation of tumor models, mutation analysis, the role of fallopian tube origin in cancer development, metastasis patterns, and insights from clinical trials.
最新文献
PARP inhibitor maintenance takes advantages in advanced epithelial ovarian cancer but May show a negative impact while recurrence occurs: a multi-center retrospective study in Taiwan

article Full Text OpenAlex

Impact of Adjuvant Radiotherapy on Survival of Patients with Stage I-II Endometrial Cancer

article Full Text OpenAlex

Global, regional, and national burden of ovarian cancer due to high BMI, 1990–2021 and projections to 2050: a systematic analysis based on the global burden of disease 2021 study

article Full Text OpenAlex

Chemoresistance in ovarian cancer (I)

article Full Text OpenAlex

The role of secondary cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for treating recurrent ovarian cancer

article Full Text OpenAlex

Molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer (PORTEC-4a): results of a randomised, open-label, phase 3, multicentre, non-inferiority trial

article Full Text OpenAlex

Association of platinum-based chemotherapy with survival in ovarian carcinosarcoma: a retrospective 2-center cohort study

article Full Text OpenAlex

Phase II Trial of Ribociclib Plus Letrozole in Women With Recurrent Low-Grade Serous Carcinoma of the Ovary, Fallopian Tube, or Peritoneum: A GOG Partners Trial (GOG 3026)

article Full Text OpenAlex

Experiences of women with ovarian cancer in 22 low-income and middle-income countries (Every Woman Study LMICs): a cross-sectional study

article Full Text OpenAlex

Durvalumab with carboplatin/paclitaxel and bevacizumab followed by durvalumab and bevacizumab with or without olaparib maintenance in newly diagnosed non-BRCA-mutated advanced ovarian cancer

article Full Text OpenAlex

近5年高被引文献
Overview of the 2022 WHO Classification of Thyroid Neoplasms

review Full Text OpenAlex 1019 FWCI135.1936

FIGO staging of endometrial cancer: 2023

article Full Text OpenAlex 835 FWCI252.4772

Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer

article Full Text OpenAlex 733 FWCI220.2946

Polycystic ovary syndrome

review Full Text OpenAlex 668 FWCI113.1104

European Journal of Gynaecological Oncology

paratext Full Text OpenAlex 582 FWCI0

Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

article Full Text OpenAlex 581 FWCI101.6878

Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology

article Full Text OpenAlex 514 FWCI151.9701

Overall Survival With Maintenance Olaparib at a 7-Year Follow-Up in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial

article Full Text OpenAlex 443 FWCI42.9022

Global epidemiology of epithelial ovarian cancer

review Full Text OpenAlex 420 FWCI231.4512

Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing

review Full Text OpenAlex 403 FWCI70.6135